PharmaForce, Inc., announced today that it has received approval from the U.S. FDA for its ANDA for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP, a generic version of Schering Corporation's Celestone Soluspan.
The details can be read here.
No comments:
Post a Comment